The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online December 10, 2007
doi:10.1084/jem.20071239
The Journal of Experimental Medicine, Vol. 204, No. 13, 3235-3245
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Sutterwala et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutterwala, F. S.
Right arrow Articles by Flavell, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutterwala, F. S.
Right arrow Articles by Flavell, R. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome

Fayyaz S. Sutterwala1,2, Lilia A. Mijares2,4, Li Li2,4, Yasunori Ogura1, Barbara I. Kazmierczak2,4, and Richard A. Flavell1,3

1 Department of Immunobiology, 2 Section of Infectious Diseases, 3 Howard Hughes Medical Institute, and 4 Section of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520

CORRESPONDENCE Richard A. Flavell: richard.flavell{at}yale.edu; OR Barbara I. Kazmierczak: barbara.kazmierczak{at}yale.edu

Pseudomonas aeruginosa is a Gram-negative bacterium that causes opportunistic infections in immunocompromised individuals. P. aeruginosa employs a type III secretion system to inject effector molecules into the cytoplasm of the host cell. This interaction with the host cell leads to inflammatory responses that eventually result in cell death. We show that infection of macrophages with P. aeruginosa results in activation of caspase-1 in an IPAF-dependent, but flagellin-independent, manner. Macrophages deficient in IPAF or caspase-1 were markedly resistant to P. aeruginosa–induced cell death and release of the proinflammatory cytokine interleukin (IL)-1β. A subset of P. aeruginosa isolates express the effector molecule exoenzyme U (ExoU), which we demonstrate is capable of inhibiting caspase-1–driven proinflammatory cytokine production. This study shows a key role for IPAF and capase-1 in innate immune responses to the pathogen P. aeruginosa, and also demonstrates that virulent ExoU-expressing strains of P. aeruginosa can circumvent this innate immune response.


Abbreviations used: CARD, caspase activation and recruitment domain; LDH, lactate dehydrogenase; MOI, multiplicity of infection; TTSS, type III secretion system.

B.I. Kazmierczak and R.A. Flavell contributed equally to this paper.

F.S. Sutterwala's present address is Inflammation Program, Dept. of Medicine, University of Iowa, Coralville, IA 52241.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS